Efficacy Study of Minoxidil Lotion Versus Combined Minoxidil and Finasteride Lotion to Treat Male Pattern Hair Loss
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01391156|
Recruitment Status : Completed
First Posted : July 11, 2011
Last Update Posted : July 20, 2012
|Condition or disease||Intervention/treatment||Phase|
|Androgenetic Alopecia||Drug: 3%Minoxidil lotion Drug: 3% Minoxidil with 0.1% Finasteride lotion||Phase 3|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||40 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|
|Official Title:||Efficacy of 3% Minoxidil Versus Combined 3% Minoxidil and 0.1% Finasteride for Male Pattern Hair Loss: a Randomized, Double-blinded, Comparative Study|
|Study Start Date :||March 2011|
|Actual Primary Completion Date :||March 2012|
|Actual Study Completion Date :||March 2012|
Drug: 3%Minoxidil lotion
3% Minoxidil lotion apply two times a day
|Active Comparator: MinoxidilFinasteride||
Drug: 3% Minoxidil with 0.1% Finasteride lotion
3% Minoxidil with 0.1% Finasteride lotion apply two times a day.
- The mean change of hair count from baseline and 6 months [ Time Frame: baseline and 6 months ]Total hair count on the vertex is measured on 1 cm2 circular area. The mean change in hair count is compared at baseline and 6 months.The significance of change is determined by Unpaired t Test.
- Global photographic assessment by dermatologists [ Time Frame: baseline and 6 months ]Photographs of the vertex scalp are taken at baseline and 6 months. A panel of 3 dermatologists assesssed the change in hair growth using a 7-point scale.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01391156
|Mae Fah Luang University Hospital(Bangkok)|
|Principal Investigator:||Chuchai Tanglertsampan, MD||Mae Fah Luang University Hospital(Bangkok)|